‍Tempest Therapeutics (NASDAQ:TPST) stock is skyrocketing on Wednesday as the clinical-stage oncology company prepares to release new study results.

Tempest Therapeutics says that it will release those results before markets open this morning. The company also intends to hold a conference call at 8:30 a.m. Eastern Time to provide investors with additional insight into the study.

‍

Check out the chart here:

Track all markets on TradingView

‍

Disclaimer: This content is made for entertainment purposes only. This is not financial advice.